Dmytro Maltsev | Gene Regulation Epigenetics | Best Review Paper Award

Posted on by sciencefather

Mr. Dmytro Maltsev | Gene Regulation Epigenetics | Best Review Paper Award

Mr. Dmytro Maltsev , O’Bogomolets National Medical University , Ukraine

Dr. Dmytro Maltsev is a Ukrainian neuroimmunologist, physician-scientist, and clinical researcher with a PhD in medicine. He serves as the head of the Laboratory of Immunology and Molecular Biology at the Research Institute of Experimental and Clinical Medicine, O’Bogomolets National Medical University, Kyiv. His extensive body of work spans neuroimmunology, autoimmune encephalitis, herpesvirus infections, and immune deficiencies. He is the author of 29 books and over 340 scientific papers, with 50 indexed in Scopus. His work has earned several prestigious awards, including recognition from the National Academy of Sciences of Ukraine and international congresses. He actively collaborates with institutions like the Mayo Clinic (USA) and the Institute of Neurosurgery (Ukraine). Dr. Maltsev is a member of multiple professional societies, including the European Academy of Neurology. His groundbreaking GBINS protocol for autistic spectrum disorder highlights his contributions to precision medicine and multidisciplinary approaches in neuropsychiatric care.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Pioneering Work:
    Dr. Maltsev’s systematic review on herpesviral encephalitis presents a groundbreaking clinic-radiological classification, offering a unifying framework that enhances clinical diagnostics and therapeutic planning.

  2. Depth and Breadth of Expertise:
    The review showcases deep neuroimmunological insight, drawing from over 340 publications, including 50 in SCOPUS, and extensive experience in both clinical and laboratory settings.

  3. Interdisciplinary Integration:
    He combines advanced techniques—PCR, ELISA, western blot, flow cytometry—with clinical observations, resulting in practical classifications and diagnostic pathways.

  4. Relevance and Timeliness:
    The review addresses a critical gap in understanding viral encephalitides, which are often misdiagnosed or under-reported, contributing to early interventions and improved patient outcomes.

  5. International Collaboration:
    Collaborative ties with the Mayo Clinic (USA) and leading Ukrainian research institutions add credibility and global relevance to his work.

  6. Proven Impact:
    Recognized for prior scientific excellence through national and international awards, including recognition from the National Academy of Sciences of Ukraine and the World Congress of Immunopathology.

🧭 Areas for Improvement:

  1. Editorial Involvement:
    Currently, Dr. Maltsev does not hold editorial roles, which could enhance his influence in shaping the field’s publication standards and peer-review frameworks.

  2. Digital Science Communication:
    Expanding public engagement via open-access formats, social media science explainers, or video summaries would amplify the reach of his reviews beyond academia.

  3. Visual Data Representation:
    While the review is methodically comprehensive, adding infographics, visual summaries, or interactive diagnostic flowcharts could enhance reader accessibility, particularly for multidisciplinary teams.

🎓 Education:

Dr. Dmytro Maltsev pursued his medical education and PhD at O’Bogomolets National Medical University in Kyiv, Ukraine. Early in his academic career, he displayed an interest in immunopathology and clinical biology. His PhD focused on the clinical and immunological aspects of herpesvirus infections and their role in neuroinflammatory diseases. His educational path included specialization in molecular biology techniques such as PCR, ELISA, immunofluorescence, and flow cytometry. His training also incorporated translational research and clinical diagnostics, equipping him with a multidisciplinary approach essential for modern neuroimmunology. With further professional development in clinical immunology and collaboration with international research groups, including the Mayo Clinic, Dr. Maltsev has refined his knowledge in personalized medicine. He actively mentors postgraduate students, and his research findings are frequently integrated into educational materials, including textbooks and monographs used in university-level instruction throughout Ukraine and abroad.

💼 Professional Experience:

Dr. Dmytro Maltsev has over 20 years of professional experience in neuroimmunology and molecular medicine. As the head of the Laboratory of Immunology and Molecular Biology at O’Bogomolets National Medical University, he leads research on immune system dysfunction, neurodevelopmental disorders, and viral neuropathology. His professional journey includes clinical consultancy, authorship of 29 medical books, and over 340 published studies. He has completed 8 major research projects and collaborated on 4 industry-funded studies. Dr. Maltsev also holds 16 patents and actively participates in international scientific communities. His work spans diagnostics, therapy innovation, and personalized medicine, including the creation of GBINS, a treatment framework for children with autism spectrum disorders. Recognized for pioneering work on minor immunodeficiencies and viral encephalitis classifications, he has received multiple national and international awards. Dr. Maltsev collaborates globally with neurologists and immunologists, contributing to consensus guidelines, systematic reviews, and cross-continental case studies.

🔬 Research Focus:

Dr. Maltsev’s research focuses on neuroimmunology, specifically immune-related neurological and psychiatric disorders. He investigates immunodeficiency syndromes, herpesvirus-induced encephalitis, autoimmune epilepsies, and autism spectrum disorders (ASD) associated with folate cycle genetic deficiencies. His work emphasizes personalized, multidisciplinary treatments through laboratory diagnostics like PCR, ELISA, immunoblotting, immunofluorescence, and flow cytometry. A core achievement is the GBINS protocol, offering a targeted therapy model for children with ASD. He also researches immunoglobulin E deficiency and alpha/beta-defensin involvement in oral cancer complications. His aim is to bridge immune dysfunction with neurological pathologies, improving diagnostic accuracy and patient outcomes. By classifying new immune-related diseases and pioneering treatment options, Dr. Maltsev contributes significantly to immunotherapy and neurorehabilitation. He also explores how AI can enhance diagnosis and therapy across various disciplines. His dedication to translational research supports the development of individualized care protocols, with ongoing global collaborations in Europe, the USA, and beyond.

📚 Publication Top Notes:

  1. 🧠 Clinic-radiological classification of herpesviral encephalitis in humans (Systematic review)

  2. 🧬 Integrative concept of pathogenesis and GBINS personalized multidisciplinary approach to ASD in children

  3. 💉 Risk factors for grade III radiation-induced mucositis in oral/oropharyngeal cancer therapy

  4. 🧫 Microbial infections in children with ASD and genetic folate cycle deficiency

  5. 🧪 Primary minor immunodeficiencies as a cause of immune-dependent pathology (Systematic review)

  6. 🌍 Global presence and penetrance of CSF1-related disorder

  7. 💊 Treatment of reactivated EBV, HHV-6, HHV-7 in children with ASD and folate cycle disruption

  8. 🤖 Trends in the use of AI in diagnosis and treatment

  9. 🛡️ Alpha/beta-defensins’ influence on immunity in oral/oropharyngeal cancer

  10. 🌐 Global presence of CSF1R-Related disorder: A multinational case series

🏁 Conclusion:

Dr. Dmytro Maltsev is highly deserving of the Best Review Paper Award for his exemplary scholarly contribution titled:
“Clinic-radiological classification of herpesviral encephalitis in humans (Systematic Review)”, published in the Journal of NeuroVirology (2025).

His work offers clinical utility, theoretical innovation, and a robust, evidence-based approach to a complex neuroinfectious condition. With continued emphasis on global engagement and editorial leadership, Dr. Maltsev is poised to remain a key thought leader in neuroimmunology.

Xinying Li | Microbiology, Molecular Biology | Best Researcher Award

Posted on by sciencefather

Ms. Xinying Li | Microbiology, Molecular Biology | Best Researcher Award

Ms. Xinying Li , School of Medicine, Anhui University of Science and Technology , China

Xinying Li is a graduate student pursuing her Master’s degree in Clinical Laboratory Diagnostics at the School of Medicine, Anhui University of Science and Technology, China. With a foundational background in Medical Laboratory Technology from Qilu Medical University, she is passionate about advancing the field of clinical diagnostics and molecular research. Xinying’s research focuses on microbial genomics, cancer biomarkers, and the pathogenesis of infectious diseases. She is particularly interested in precision medicine, specifically targeting Helicobacter pylori infections and gastric cancer. In her work, she has contributed significantly to the identification and characterization of novel microbial strains, such as Massilia shenzhen sp. nov., and is involved in groundbreaking research on early detection biomarkers for cancer. As a proactive researcher and author, she is dedicated to improving clinical practices and diagnostic tools to address critical health challenges in both infectious diseases and cancer treatment.

Publication Profile:

Orcid

Strengths for the Award:

Xinying Li demonstrates exceptional potential and impact in her field, making her an ideal candidate for the Best Researcher Award. Her research contributions span critical areas of clinical diagnostics, microbial genomics, and cancer biomarkers, which are of paramount importance in improving patient care. She has made significant strides in exploring novel biomarkers for gastric cancer through METTL7A, a promising biomarker that could aid in early diagnosis and personalized treatment. In addition, her pioneering work on the characterization of Massilia shenzhen sp. nov. and its pathogenicity in neonatal sepsis addresses urgent needs in microbiology and infectious disease treatment. Xinying’s research on Helicobacter pylori is also noteworthy, as it aims to refine precision medicine strategies and improve treatment outcomes. With published works in top journals and an active role in advancing molecular diagnostics, she has already demonstrated a profound impact on both scientific literature and clinical practices. Her ability to conduct independent research, coupled with a passion for medical innovation, sets her apart as a rising star in the field.

Areas for Improvement:

While Xinying Li has shown considerable promise, there are several areas where her research trajectory could benefit from further expansion:

  1. Broader Collaboration and Networking: Although her work has been impactful, collaborating with international researchers and interdisciplinary teams could open doors to more innovative and global solutions, especially in the areas of microbiome research and personalized medicine.
  2. Industry Engagement: Increasing her involvement with clinical or industry-sponsored projects would allow her to bridge the gap between lab research and real-world applications, especially in therapeutic innovations and diagnostic tools.
  3. Public Visibility and Outreach: Expanding her visibility within scientific communities through conferences and media outlets will help elevate her already impressive body of work and attract more collaborative opportunities.

Education:

Xinying Li completed her Bachelor’s degree in Medical Laboratory Technology from Qilu Medical University, one of the most renowned institutions in China for medical research and education. She is currently enrolled in the Master’s program in Clinical Laboratory Diagnostics at Anhui University of Science and Technology, where she has expanded her knowledge and research skills in the fields of clinical microbiology and cancer diagnostics. Throughout her academic career, Xinying has shown great promise in both theoretical and practical aspects of medical research. She has been trained in advanced laboratory techniques, including genomic analysis, proteomic profiling, and pathogen identification. Her educational path has provided her with a strong foundation in clinical laboratory sciences, allowing her to explore new frontiers in microbial genomics, precision medicine, and molecular diagnostics. Her passion for science is matched by her drive to improve clinical care through innovative research.

Experience:

Xinying Li’s research career has been marked by notable achievements in the fields of microbiology, genomics, and clinical diagnostics. She is currently engaged in multiple cutting-edge research projects, including the identification of novel biomarkers for gastric cancer and studying the pathogenicity of newly discovered microbial strains. One of her key contributions is her work on Massilia shenzhen sp. nov., a bacterium isolated from the blood of a premature infant with sepsis. This work has the potential to improve the understanding of bacterial resistance and pathogenic mechanisms. In addition, Xinying has made significant contributions to the field of Helicobacter pylori infections, particularly in exploring precision treatments to combat this widespread pathogen. Her research has been published in prestigious journals, and she actively collaborates with professionals in the fields of infectious diseases and oncology. With her growing portfolio of research, Xinying has proven to be an emerging leader in medical diagnostics and microbial genomics.

Research Focus:

Xinying Li’s research primarily focuses on clinical diagnostics, microbial genomics, and cancer biomarkers. She is deeply involved in studies that explore new ways to diagnose and treat infectious diseases and cancer, aiming to bridge the gap between laboratory science and clinical practice. A key area of her research is investigating the role of METTL7A as a potential biomarker for early-stage gastric cancer. Her work also includes the characterization of Massilia shenzhen sp. nov., a novel pathogen that was isolated from a premature infant’s blood during sepsis, with a focus on its antibiotic resistance and pathogenic properties. Additionally, she is exploring the precision treatment of Helicobacter pylori infections, which are a major cause of gastrointestinal disorders. Through these research initiatives, Xinying aims to contribute to the development of personalized treatment plans and improve patient outcomes. Her work exemplifies the importance of combining genomic analysis with clinical applications to address complex health challenges.

Publication Top Notes:

  1. “Research progress on precision treatment of Helicobacter pylori infection.” 🦠 Chinese Journal of Clinical Infectious Diseases, 2022, 15(5): 388-394.
  2. “Characterization of Massilia shenzhen sp. nov. isolated from a premature infant with sepsis.” 🔬 International Journal of Clinical Microbiology (under review).
  3. “METTL7A as a potential biomarker for gastric cancer diagnosis.” 🎗️ Journal of Cancer Research and Clinical Oncology (in progress).
  4. “Exploring novel therapeutic approaches to treat Helicobacter pylori infection.” 💉 Asian Journal of Gastroenterology (under review).

Conclusion:

Xinying Li’s research contributions, particularly her work on gastric cancer biomarkers, microbial genomics, and precision treatments for infectious diseases, have the potential to transform clinical diagnostics and therapeutic approaches. Her dedication to advancing medical science and improving patient outcomes is clear from her impressive track record of publications and innovative research. With her strong academic foundation and groundbreaking work, Xinying Li is unquestionably deserving of the Best Researcher Award. Expanding her collaborations and industry engagement will only amplify the impact of her future research, making her a leading figure in medical diagnostics and infectious disease research.